Ophthalmology
Transforming the treatment of serious, vision-threatening diseases
Millions of people around the world are impacted by vision-threatening conditions, which can dramatically affect a person’s independence and quality of life. For more than 20 years, Regeneron has been relentlessly pursuing groundbreaking innovations in eye care science to help make a meaningful difference in their lives.
Our transformative scientific research began with a focus on understanding how blocking the growth of new blood vessels (angiogenesis) can decrease the ability of fluid to pass through blood vessels in the eye. Our research has since brought fundamental change to the treatment paradigm for serious eye diseases, including wet age-related macular degeneration, diabetic retinopathy, diabetic macular edema, macular edema following retinal vein occlusion and retinopathy of prematurity. Fortunately, patients who have been diagnosed with these serious eye diseases now have options to treat them.
Our ongoing commitment to researching retinal diseases
Our deep expertise in angiogenesis now serves as our foundation for ongoing innovation and fuels our ambition to develop new solutions for patients and eye care. Our robust and diverse research and development program in ophthalmology includes efforts to potentially address many other serious eye diseases, including geographic atrophy, glaucoma and certain inherited retinal diseases. In addition to the proprietary Trap technology that was the basis for our leading therapeutic, we use monoclonal antibodies and cutting-edge modalities like RNA interference and gene therapy as the basis for new potential medicines.
Perspectives on clinical innovation in ophthalmology
With our decades of research experience in ophthalmology, we have developed unique and valuable insights that guide our work today. Our approach combines scientific rigor with collaboration—partnering with clinicians and researchers to ensure our innovations meet real-world patient needs and deliver meaningful impact. Check out these videos to hear:
- Insights from Regeneron ophthalmology experts about our scientific approach and learnings that are driving our continued innovation today
- Perspectives from a roundtable discussion where leading retina specialists talked about patient-centered research, the importance of collaboration, and reflections on their ophthalmology careers
Video Title
Video Description
Continue Watching
Eye on the Experts Roundtable: Following Your Passion in Ophthalmology
Accomplished physicians discuss the most rewarding parts of their careers, including advancing research to develop new treatments that have the potential to make a difference for millions of patients.
Eye on the Experts Roundtable: The Importance of Mentorship in Ophthalmology
Discover how mentorship and networking have shaped the journeys of leading ophthalmology experts, and why building strong, diverse connections is essential to advancing innovation and empowering the next generation of leaders in eye care.
Eye on the Experts Roundtable: The Future of Retina
Ophthalmology leaders share what excites them about the future of retina—from gene therapy and personalized medicine to the transformative power of AI and imaging technology.
Eye on the Experts Roundtable: Making Progress for Patients Through Collaboration
Ophthalmology experts share best practices for successful collaboration between industry, healthcare professionals, and the retinal community that help drive innovation and improve patient care.
Eye on the Experts: Insights from 20 Years in Ophthalmology Research
Listen to Regeneron Ophthalmology experts talk about our impact and the critical need to collaborate with the retinal community from the beginning to create meaningful change.
Eye on the Experts: Building on Legacy to Drive Innovation
Watch Regeneron Ophthalmology leaders discuss how we’re leveraging our expertise in angiogenesis to keep innovating for patients with vision-threatening conditions.